<DOC>
	<DOCNO>NCT00161759</DOCNO>
	<brief_summary>The purpose study assess Fibrin Sealant 4IU safe efficacious staple ( current standard care ) achieve fixation skin graft wound heal subject burn wound . Each subject receive staple well FS 4IU comparable treatment site .</brief_summary>
	<brief_title>Safety Efficacy Study Fibrin Sealant ( FS 4IU ) Skin Graft Fixation Wound Healing Subjects With Burn Wounds</brief_title>
	<detailed_description />
	<mesh_term>Burns</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Written inform consent obtain either subject subject ’ legally acceptable representative prior screening activity Male female age &gt; = 6 &lt; = 65 year age Total burn wound measure &lt; = 40 % TBSA include deep partial thickness/full thickness area require autologous split thickness sheet skin graft The selected test area consist contiguous , deep partial thickness/full thickness burn wound 2 % 8 % TBSA , divide two approximate half two bilateral wound ( measure 1 % 4 % TBSA ) Females childbearing potential negative urine serum pregnancy test admission Able willing comply procedure require protocol Conductive electrical burn chemical burn Digits , head , genitalia , palm hand , sol foot , face exclude test site Circumferential burn exclude test area 4th 5th degree burn Test area infection determine clinically Investigator prior surgery Venous arterial vascular disorder directly affect designate test area Known immune deficiency disorder , either congenital acquire Chronically malnourish determine clinically investigator prior surgery ( Investigators responsible determine subject chronically malnourish screen process . Investigators take consideration follow parameter : Medical history physical appearance , subject ’ body mass index , significant laboratory finding ) Severe respiratory problem concurrent head trauma hospital admission Any chronic condition require use systemic corticosteroid 30 day prior study entry anytime course study Known newly diagnose diabetic require insulin Any acute chronic concurrent medical condition ( ) Investigator ’ opinion contraindication skin graft study participation Known suspect hypersensitivity bovine protein Concurrent participation another clinical trial investigational agent use . ( Subjects must enrol another clinical trial within 30 day enrol trial ) .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>